PP_1170x120_10-25-21

PEPFAR

Aurobindo gets tentative FDA approval for HIV drug

Aurobindo gets tentative FDA approval for HIV drug

HYDERABAD, India — Aurobindo Pharma Ltd. has gained tentative approval from the Food and Drug Administration for dolutegravir 50 mg, an HIV medication. Aurobindo said Thursday that the move enables the company to launch the product, a generic equivalent of Tivicay from ViiV Healthcare, in the President’s Emergency Plan For AIDS Relief (PEPFAR) market. Launched

Adheris Health